Litcius/Paper detail

Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors

Juan Montoro, José Luís Piñana, Juan Carlos Hernández‐Boluda, Rafael Hernani, Ignacio Lorenzo, Ariadna Pérez, Manuel Guerreiro, Aitana Balaguer‐Roselló, Guillermo Sanz, Carlos Carretero, Eliseo Albert, David Navarro, Miguel Á. Sanz, Carlos Solano, Jaime Sanz

2020Bone Marrow Transplantation57 citationsDOI

Topics & Concepts

MedicineCumulative incidenceCyclophosphamideHematopoietic stem cell transplantationTransplantationIncidence (geometry)SirolimusGraft-versus-host diseaseInternal medicineGastroenterologySurgeryChemotherapyPhysicsOpticsHematopoietic Stem Cell TransplantationPolyomavirus and related diseasesRenal Transplantation Outcomes and Treatments
Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors | Litcius